Cargando…
Technical Note: Characterization of technology to detect residual injection site radioactivity
PURPOSE: Each year in the United States, approximately 18.5 million nuclear medicine procedures are performed. Various quality control measures are implemented to reduce image errors and improve quantification of radiotracer distribution. However, there is currently no routine or timely feedback abo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850203/ https://www.ncbi.nlm.nih.gov/pubmed/30972762 http://dx.doi.org/10.1002/mp.13536 |
_version_ | 1783469375023480832 |
---|---|
author | Knowland, Josh Lipman, Samantha Lattanze, Ron Kingg, Jesse Ryan, Kelley Perrin, Steven |
author_facet | Knowland, Josh Lipman, Samantha Lattanze, Ron Kingg, Jesse Ryan, Kelley Perrin, Steven |
author_sort | Knowland, Josh |
collection | PubMed |
description | PURPOSE: Each year in the United States, approximately 18.5 million nuclear medicine procedures are performed. Various quality control measures are implemented to reduce image errors and improve quantification of radiotracer distribution. However, there is currently no routine or timely feedback about the quality of the radiotracer injection. One potential solution to evaluate the injection quality is to place a topical scintillation sensor near the injection site to record the presence of residual activity. This work investigates a sensor design for identification of injections where the prescribed radioactive activity is not fully delivered into the patient's circulation (an infiltration). METHODS: The sensor consists of a single unshielded bismuth germanate (BGO) crystal (3 mm × 3 mm × 3 mm). Using radioactive sources with gamma energies that span the range commonly used in nuclear medicine, we quantified energy resolution and linearity. Additionally, we computed sensitivity by comparing the calculated incident activity to the activity measured by the sensor. Sensor output linearity was calculated by comparing measured data against the radioactive decay of a source over multiple half‐lives. The sensor incorporates internal temperature feedback used to compensate for ambient temperature fluctuations. We investigated the performance of this compensation over the range of 15°C–35°C. RESULTS: Energy spectra from four sensors were used to calculate the energy resolution: 67% for (99m)Tc (141 keV), 67% for (133)Ba (344 keV), 42% for (18)F (511 keV), and 32% for (137)Cs (662 keV). Note that the energy used for (133)Ba is a weighted average of the three photon emissions nearest to the most abundant (356 keV). Sensor energy response was linear with a difference of 1%–2% between measured and predicted values. Energy‐dependent detector sensitivity, defined as the ratio of measured photons to incident photons for a given isotope, decreased with increasing photon energy from 55.4% for (99m)Tc (141 keV) to 3.3% for (137)Cs (662 keV). Without compensation, error due to temperature change was as high as 53%. Temperature compensation reduced the error to less than 1.4%. Sensor output linearity was tested to as high as 210 kcps and the maximum magnitude error was 4%. CONCLUSIONS: The performance of the sensor was adequate for identification of excessive residual activity at an injection site. Its ability to provide feedback may be useful as a quality control measure for nuclear medicine injections. |
format | Online Article Text |
id | pubmed-6850203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68502032019-11-18 Technical Note: Characterization of technology to detect residual injection site radioactivity Knowland, Josh Lipman, Samantha Lattanze, Ron Kingg, Jesse Ryan, Kelley Perrin, Steven Med Phys QUANTITATIVE IMAGING AND IMAGE PROCESSING PURPOSE: Each year in the United States, approximately 18.5 million nuclear medicine procedures are performed. Various quality control measures are implemented to reduce image errors and improve quantification of radiotracer distribution. However, there is currently no routine or timely feedback about the quality of the radiotracer injection. One potential solution to evaluate the injection quality is to place a topical scintillation sensor near the injection site to record the presence of residual activity. This work investigates a sensor design for identification of injections where the prescribed radioactive activity is not fully delivered into the patient's circulation (an infiltration). METHODS: The sensor consists of a single unshielded bismuth germanate (BGO) crystal (3 mm × 3 mm × 3 mm). Using radioactive sources with gamma energies that span the range commonly used in nuclear medicine, we quantified energy resolution and linearity. Additionally, we computed sensitivity by comparing the calculated incident activity to the activity measured by the sensor. Sensor output linearity was calculated by comparing measured data against the radioactive decay of a source over multiple half‐lives. The sensor incorporates internal temperature feedback used to compensate for ambient temperature fluctuations. We investigated the performance of this compensation over the range of 15°C–35°C. RESULTS: Energy spectra from four sensors were used to calculate the energy resolution: 67% for (99m)Tc (141 keV), 67% for (133)Ba (344 keV), 42% for (18)F (511 keV), and 32% for (137)Cs (662 keV). Note that the energy used for (133)Ba is a weighted average of the three photon emissions nearest to the most abundant (356 keV). Sensor energy response was linear with a difference of 1%–2% between measured and predicted values. Energy‐dependent detector sensitivity, defined as the ratio of measured photons to incident photons for a given isotope, decreased with increasing photon energy from 55.4% for (99m)Tc (141 keV) to 3.3% for (137)Cs (662 keV). Without compensation, error due to temperature change was as high as 53%. Temperature compensation reduced the error to less than 1.4%. Sensor output linearity was tested to as high as 210 kcps and the maximum magnitude error was 4%. CONCLUSIONS: The performance of the sensor was adequate for identification of excessive residual activity at an injection site. Its ability to provide feedback may be useful as a quality control measure for nuclear medicine injections. John Wiley and Sons Inc. 2019-04-29 2019-06 /pmc/articles/PMC6850203/ /pubmed/30972762 http://dx.doi.org/10.1002/mp.13536 Text en © 2019 Lucerno Dynamics. Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | QUANTITATIVE IMAGING AND IMAGE PROCESSING Knowland, Josh Lipman, Samantha Lattanze, Ron Kingg, Jesse Ryan, Kelley Perrin, Steven Technical Note: Characterization of technology to detect residual injection site radioactivity |
title | Technical Note: Characterization of technology to detect residual injection site radioactivity |
title_full | Technical Note: Characterization of technology to detect residual injection site radioactivity |
title_fullStr | Technical Note: Characterization of technology to detect residual injection site radioactivity |
title_full_unstemmed | Technical Note: Characterization of technology to detect residual injection site radioactivity |
title_short | Technical Note: Characterization of technology to detect residual injection site radioactivity |
title_sort | technical note: characterization of technology to detect residual injection site radioactivity |
topic | QUANTITATIVE IMAGING AND IMAGE PROCESSING |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850203/ https://www.ncbi.nlm.nih.gov/pubmed/30972762 http://dx.doi.org/10.1002/mp.13536 |
work_keys_str_mv | AT knowlandjosh technicalnotecharacterizationoftechnologytodetectresidualinjectionsiteradioactivity AT lipmansamantha technicalnotecharacterizationoftechnologytodetectresidualinjectionsiteradioactivity AT lattanzeron technicalnotecharacterizationoftechnologytodetectresidualinjectionsiteradioactivity AT kinggjesse technicalnotecharacterizationoftechnologytodetectresidualinjectionsiteradioactivity AT ryankelley technicalnotecharacterizationoftechnologytodetectresidualinjectionsiteradioactivity AT perrinsteven technicalnotecharacterizationoftechnologytodetectresidualinjectionsiteradioactivity |